BioSyent Inc. (OTCMKTS:BIOYF – Get Free Report) traded up 0.9% on Thursday. The stock traded as high as $12.42 and last traded at $12.42. 1,639 shares traded hands during mid-day trading, a decline of 32% from the average session volume of 2,396 shares. The stock had previously closed at $12.31.
BioSyent Price Performance
The business has a 50-day moving average of $11.72 and a 200-day moving average of $10.83.
About BioSyent
BioSyent Inc is a Canadian specialty pharmaceutical company focused on acquiring, licensing, developing and commercializing products for the Canadian healthcare market. Through its BioSyent Pharma subsidiary, the company concentrates on prescription and non-prescription therapies that address specific medical needs and can be supported through focused sales and marketing activities.
BioSyent’s product portfolio has included FeraMAX, an oral iron supplement designed to help treat or prevent iron deficiency and iron-deficiency anemia.
Read More
- Five stocks we like better than BioSyent
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.
